You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune suppressive therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Aplastic Anemia Trial in Boston, Salt Lake City (drug, procedure, radiation)

Recruiting
  • Severe Aplastic Anemia
  • Boston, Massachusetts
  • +1 more
Jan 13, 2023

Suppressive Antibiotic Therapy for Endocarditis

Recruiting
  • Endocarditis
    • Strasbourg, France
      Service des Maladies Infectieuses et Tropicales - CHU de Strasbo
    Oct 30, 2023

    HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

    Not yet recruiting
    • HIV-1-infection
    • ChAdOx1.tHIVconsv1
    • +7 more
    • San Diego, California
    • +11 more
    Oct 4, 2023

    Safety of Suppressive Therapy With DALBAVANCINE in Device

    Completed
    • Prosthesis-related Infections
    • Dalbavancin Injection
    • Tourcoing, France
      CH Tourcoing
    Oct 12, 2023

    HIV Trial in United States (BMS-936559, Placebo for BMS-936559)

    Completed
    • HIV Infections
    • Aurora, Colorado
    • +4 more
    Nov 4, 2021

    Hepatitis B Virus Trial in Puerto Rico, United States (Cemiplimab)

    Suspended
    • Hepatitis B Virus
    • Cemiplimab
    • Los Angeles, California
    • +6 more
    Dec 5, 2022

    HIV-1 Trial in Bethesda, New York (3BNC117-LS, 10-1074-LS, Sterile Saline)

    Recruiting
    • HIV-1
    • 3BNC117-LS
    • +2 more
    • Bethesda, Maryland
    • +1 more
    Jan 31, 2023

    HIV-1-infection Trial in Chapel Hill (MGD014)

    Completed
    Has Results
    • HIV-1-infection
    • MGD014
    • Chapel Hill, North Carolina
      University of North Carolina Chapel Hill
    Aug 31, 2022

    Periprosthetic Joint Infection, Antibiotic Suppression Trial (6 months of SAT, 12 months of SAT)

    Not yet recruiting
    • Suppressive Antibiotic Therapy
    • +2 more
    • 6 months of SAT
    • 12 months of SAT
    • (no location specified)
    Aug 8, 2022

    Ulcerative Colitis Trial (Roflumilast 500 Ug ORAL TABLET [Daliresp], corticosteroids +immune suppressive +amino salicylic acid)

    Not yet recruiting
    • Ulcerative Colitis
    • Roflumilast 500 Ug ORAL TABLET [Daliresp]
    • corticosteroids +immune suppressive +amino salicylic acid
    • (no location specified)
    Jan 13, 2023

    Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays

    Not yet recruiting
    • Lung Neoplasm
    • +2 more
    • Tumor samples
    • Bordeaux, France
      CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
    Aug 28, 2023

    HIV Trial in Columbus, Pittsburgh (Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, Placebo control for Trimer 4571 vaccine

    Recruiting
    • HIV Infections
    • Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant
    • +3 more
    • Columbus, Ohio
    • +1 more
    Apr 10, 2022

    HIV-1 Infection Trial in Puerto Rico, United States (Isotretinoin)

    Completed
    Has Results
    • HIV-1 Infection
    • Birmingham, Alabama
    • +14 more
    Jul 31, 2021

    Recovery From Acute Immune Failure in Septic Shock by Immune

    Recruiting
    • Severe Sepsis
      • Magdeburg, Germany
      • +1 more
      Nov 20, 2023

      Systemic Inflammatory Response Syndrome Trial in Madrid (Allogeneic thyTreg 5.000.000, Allogeneic thyTreg 10.000.000)

      Recruiting
      • Systemic Inflammatory Response Syndrome
      • Allogeneic thyTreg 5.000.000
      • Allogeneic thyTreg 10.000.000
      • Madrid, Spain
        Hospital General Universitario Gregorio Marañon
      Sep 22, 2023

      Covid-19 Patients Trial in Giza (Cupping therapy with convential medical treatment, Convential medical treatment)

      Completed
      • Covid-19 Patients
      • Cupping therapy with convential medical treatment
      • Convential medical treatment
      • Giza, Egypt
        Faculty of physical therapy
      Jun 11, 2023

      Reference Center

      Completed
      • Bone and Joint Infection
      • patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy
      • Lyon, France
        Hospices Civils de Lyon
      Jun 15, 2021

      Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

      Not yet recruiting
      • Oligometastatic Prostate Cancer
      • New York, New York
        Columbia University Irving Medical Center / NewYork-Presbyterian
      Jun 14, 2023

      Immune System Disorder Trial in Giza (Aerobic training, diet protocol)

      Recruiting
      • Immune System Disorder
      • Aerobic training
      • diet protocol
      • Giza, Egypt
        Faculty of Physical therapy, Cairo University
      Nov 20, 2023

      Ocrelizumab on Peripheral Lymphocyte Immunophenotypes With

      Not yet recruiting
      • Multiple Sclerosis
      • Istanbul, Uskudar, Turkey
        Health Sciences University Istanbul Haydarpaşa Numune Training a
      Aug 25, 2021

      Chronic GVHD Trial in United States (drug, procedure, other)

      Not yet recruiting
      • Chronic Graft Versus Host Disease
      • Tampa, Florida
      • +4 more
      Aug 10, 2023

      Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Cryoablation
      • Cryoablation combined with PD1 Inhibitor
      • (no location specified)
      Mar 28, 2023

      Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)

      Active, not recruiting
      • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
      • Rozzano, Milano, Italy
        Istituto Clinico Humanitas
      May 17, 2023

      Lung Cancer Stage IV Trial in Maastricht (Radiation)

      Not yet recruiting
      • Lung Cancer Stage IV
      • Radiation
      • Maastricht, Netherlands
        Maastricht Radiation Oncology (Maastro)
      Aug 29, 2023

      Immune Checkpoint Inhibitor Monotherapy or Combined With

      Not yet recruiting
      • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
      • Immune checkpoint inhibitor
      • Guangzhou, Guangdong, China
        Department of Minimally Invasive and Interventional Radiology, L
      Jan 30, 2023